PI
TRIB

Putnam Investments’s Trinity Biotech TRIB Stock Holding History

Putnam Investments’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-333
Closed -$903K – 1537
2015
Q2 		$903K Sell
333
-3
-0.9% -$7.79K ﹤0.01% 1241
2015
Q1 		$970K Sell
336
-12
-3% -$33.3K ﹤0.01% 1205
2014
Q4 		$913K Sell
348
-147
-30% -$380K ﹤0.01% 1195
2014
Q3 		$1.36M Buy
495
+8
+2% +$26K ﹤0.01% 1137
2014
Q2 		$1.68M Buy
487
+1
+0.2% +$3.56K ﹤0.01% 1072
2014
Q1 		$1.77M Sell
486
-25
-5% -$98.3K ﹤0.01% 1074
2013
Q4 		$1.93M Sell
511
-8
-2% -$28.8K ﹤0.01% 1058
2013
Q3 		$1.69M Sell
519
-45
-8% -$132K ﹤0.01% 1105
2013
Q2 		$1.43M Buy
+564
New +$1.4M ﹤0.01% 1142

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Putnam Investments's TRIB Position: Q3 2015 in Review

Putnam Investments sold out of Trinity Biotech (TRIB) in Q3 2015, closing a stake of 333 shares — an estimated $903K sold.

Putnam Investments first reported a position in TRIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.93M in Q4 2013. 92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

  • Putnam Investments reported no remaining Trinity Biotech position as of Q3 2015 after selling out during the quarter.
  • Putnam Investments sold 333 Trinity Biotech shares in Q3 2015, an estimated $903K.
  • Putnam Investments first reported a position in Trinity Biotech in Q2 2013 and held it in 9 quarters.
  • Putnam Investments's Trinity Biotech position peaked at $1.93M in Q4 2013.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Putnam Investments's 13F filing for Q3 2015, filed 16 Nov 2015.